Randomized, two-way, two- period, single oral dose, open- label, crossover, bioequivalence study to compare Diclofenac Potassium powder for oral solution (50 mg diclofenac potassium) manufactured by Riyadh Pharma versus Catafast® powder for oral solution (50 mg diclofenac potassium) manufactured by Mipharm S.p.A., in healthy subjects under fasting condition.
2022-06-30
عنوان الدراسة
Randomized, two-way, two- period, single oral dose, open- label, crossover, bioequivalence study to compare Diclofenac Potassium powder for oral solution (50 mg diclofenac potassium) manufactured by Riyadh Pharma versus Catafast® powder for oral solution (50 mg diclofenac potassium) manufactured by Mipharm S.p.A., in healthy subjects under fasting condition.
داعم الدراسة
Saudi Ajal
دواء الدراسة
DICLOFENAC POTASSIUM
رقم بروتوكول الدراسة
42856
حالة الدراسة
Ongoing
موقع الدراسة
Saudi Ajal
مرحلة الدراسة
1
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.